摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

hibiscus acid | 27750-11-4

中文名称
——
中文别名
——
英文名称
hibiscus acid
英文别名
ALLO-2-hydroxycitric acid;(1S,2R)-1,2-dihydroxypropane-1,2,3-tricarboxylic acid
hibiscus acid化学式
CAS
27750-11-4
化学式
C6H8O8
mdl
——
分子量
208.125
InChiKey
ZMJBYMUCKBYSCP-AWFVSMACSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    152
  • 氢给体数:
    5
  • 氢受体数:
    8

安全信息

  • 海关编码:
    2918199090

SDS

SDS:c223a625bbfe367fc4356165a5098b3f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    hibiscus acidcalcium hydroxide 作用下, 以 为溶剂, 生成 calcium (-)-hydroxycitric acid
    参考文献:
    名称:
    WO2006/81682
    摘要:
    公开号:
  • 作为产物:
    描述:
    calcium (-)-hydroxycitric acid 生成 hibiscus acid
    参考文献:
    名称:
    WO2006/81682
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS
    申请人:Chodorowski-Kimmes Sandrine
    公开号:US20100239509A1
    公开(公告)日:2010-09-23
    The present patent application relates to a cosmetic or dermatological composition comprising, in a cosmetically or dermatologically acceptable medium, a polymer comprising: (a) a polymer backbone that may be obtained by reaction: of a polyol comprising 3 to 6 hydroxyl groups; of a monocarboxylic acid containing 6 to 32 carbon atoms; of a polycarboxylic acid comprising at least two carboxylic groups COOH, and/or of a cyclic anhydride such as a polycarboxylic acid and/or of a lactone comprising at least one carboxylic group COOH; and (b) at least one junction group linked to the said polymer backbone and capable of establishing H bonds with one or more partner junction groups, each pairing of a junction group involving at least three H (hydrogen) bonds. The patent application also concerns a cosmetic treatment process using the said composition.
    本专利申请涉及一种化妆品或皮肤科学组合物,包括在化妆品或皮肤科学上可接受的介质中,包含以下聚合物的组合物:(a) 由以下反应得到的聚合物骨架:含有3至6个羟基的多元醇;含有6至32个碳原子的一元羧酸;至少含有两个羧基COOH的多元羧酸,和/或类似多元羧酸的环酐和/或至少含有一个羧基COOH的内酯;以及(b) 至少一个连接到所述聚合物骨架的连接基团,并能够与一个或多个配对连接基团建立H键,每个连接基团的配对涉及至少三个H(氢)键。该专利申请还涉及使用所述组合物的化妆品处理过程。
  • COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION
    申请人:GIUSTINIANI Pascal
    公开号:US20090028807A1
    公开(公告)日:2009-01-29
    The present application relates to a cosmetic or pharmaceutical, in particular lipstick, composition comprising a polycondensate The application also relates to a method of cosmetic treatment using the composition, the polycondensate thus defined and a method of preparing the polycondensate.
    本申请涉及一种化妆品或药用品,特别是口红,包括聚缩酸酯的组合物。该申请还涉及一种使用该组合物进行化妆处理的方法,所述聚缩酸酯的定义以及一种制备聚缩酸酯的方法。
  • COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT
    申请人:Malle Gerard
    公开号:US20100272660A1
    公开(公告)日:2010-10-28
    The present application relates to a cosmetic or pharmaceutical composition comprising a polycondensate capable of being obtained by the reaction of the following monomers alone: of 10 to 30% by weight, relative to the total weight of the polycondensate, of one or more polyols comprising 3 to 6 hydroxyl groups; of 30 to 80% by weight, relative to the total weight of the polycondensate, of one or more linear, branched and/or cyclic, saturated or unsaturated, non-aromatic monocarboxylic acids comprising 6 to 32 carbon atoms; of 1 to 40% by weight, relative to the total weight of the polycondensate, of one or more polycarboxylic acids and/or cyclic anhydrides of such a polycarboxylic acid and/or lactones comprising at least one COOH group; and optionally of 0.1 to 15% by weight, relative to the total weight of the polycondensate, of one or more silicones having a hydroxyl and/or carboxyl functional group. The application also relates to a method of cosmetic treatment using the said composition, and the polycondensate thus defined.
    本申请涉及一种化妆品或药用组合物,包括由以下单体反应而得的聚缩酸酯:相对于聚缩酸酯的总重量,占10至30%的一种或多种含有3至6个羟基的多元醇;占30至80%的一种或多种线性、支链和/或环状、饱和或不饱和、非芳香族的单羧酸,含有6至32个碳原子;占聚缩酸酯总重量的1至40%的一种或多种多羧酸和/或多羧酸的环状酐和/或含有至少一个COOH基团的内酯;以及可选地占聚缩酸酯总重量的0.1至15%的一种或多种硅氧烷,具有羟基和/或羧基官能团。该申请还涉及使用所述组合物进行化妆处理的方法,以及如此定义的聚缩酸酯。
  • ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF
    申请人:Rimer Jeffrey D.
    公开号:US20150297545A1
    公开(公告)日:2015-10-22
    In an embodiment of the present disclosure, there is provided a composition for dissolving calcium oxalate crystals thereby inhibiting/preventing further growth of crystals. In some embodiments, such a composition comprises at least one stereoisomer of hydroxycitrate, a derivative of the organic acid citrate. Such a method comprises administering to the subject an effective amount of the aforementioned composition. In another embodiment, the present disclosure pertains to a method of treating kidney stone disorder. Such a method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition. In yet another embodiment, the present disclosure relates to a method of treating calcium oxalate stone disease. In an embodiment, the method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition.
    在本公开的实施例中,提供了一种用于溶解草酸钙晶体从而抑制/预防晶体进一步生长的组合物。在一些实施例中,这样的组合物包括至少一种羟基柠檬酸的立体异构体,这是有机酸柠檬酸的衍生物。这种方法包括向受试者施用上述组合物的有效量。在另一实施例中,本公开涉及一种治疗肾结石疾病的方法。这种方法包括向需要的受试者施用上述组合物的治疗有效量。在另一实施例中,本公开涉及一种治疗草酸钙结石疾病的方法。在一实施例中,该方法包括向需要的受试者施用上述组合物的治疗有效量。
  • Novel acyclic chiral derivatives of hibiscus acid and the process of preparing the same
    申请人:——
    公开号:US20020045769A1
    公开(公告)日:2002-04-18
    The present invention relates to a novel acyclic chiral derivatives of Hibiscus acid of formula I, 1 wherein: R 1 ═R 5 ═lower aryl or alkyl ester or substituted aryl or alkyl alcohol R 3 ═substituted aryl or alkyl ester or substituted aryl alcohol R 2 ═R4═hydroxyl or 2 and a process for preparing the same.
    本发明涉及一种新型无环手性Hibiscus酸衍生物,其化学式为I,1,其中:R1═R5═低芳基或烷基酯或取代芳基或烷基醇;R3═取代芳基或烷基酯或取代芳基醇;R2═R4═羟基或2,以及其制备方法。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物